{
    "2021-10-15": [
        [
            {
                "time": "",
                "original_text": "美国资本集团增持药明康德(02359)147.37万股，每股作价约167.47港元",
                "features": {
                    "keywords": [
                        "美国资本集团",
                        "增持",
                        "药明康德"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "北向资金恢复交易后首日净买入近27亿，再度大笔加仓新能源股",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "新能源股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-29",
                "original_text": "药明康德：将于10月29日召开董事会会议，以审议第三季业绩等事项",
                "features": {
                    "keywords": [
                        "药明康德",
                        "董事会会议",
                        "第三季业绩"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "中信建投医药大健康团队最新研究",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "大健康",
                        "研究"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "大健康"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}